查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1439240

血管接取裝置 - 全球市場考量、競爭格局、市場預測 (2030)

Vascular Access Device - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日期: 按訂單生產 | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

全球血管通路器械市場規模預計2023年將達到45.9億美元，到2030年將達到67.5億美元，2024-2030年預測期間複合年增長率為6.64%。對血管通路裝置的需求主要是由於需要使用這些裝置的慢性疾病（例如癌症、腎衰竭和心臟病）的日益流行所推動的。其他因素，例如化療使用的增加、生活方式相關疾病以及兒科患者發病率上升也可能支持市場成長。

血管接取裝置市場動態

全球慢性病和傳染病的流行預計將加速血管通路器械市場的成長。例如，根據Global Cancer Observatory data（2020），2020年全球報告了約573,000例膀胱癌病例。根據同一數據，到 2040 年，這一數字預計將達到 913,000 人。

根據上述數據，2020年全球新診斷腎癌及腎盂癌43.1萬例，預計2040年將增加至60.6萬例。

根據 Globocan (2020) 的數據，2020 年全球新增前列腺癌患者 141 萬人。根據相同的數據，預計到 2040 年將有約 224 萬新發前列腺癌病例。

根據International Society of Nephrology發布的最新數據，到2022年，全球將有8.5億人患有某種形式的腎臟疾病。此外，全世界有 530 萬至 1,050 萬人需要透析或移植。

然而，與各種血管通路裝置相關的併發症和高成本可能會限制整個血管裝置市場的成長。

血管接入設備市場細分分析

在血管通路器械市場的器械類型部分，週邊放置中心靜脈導管（PICC）類別預計將佔據最大份額。這是由於 PICC 的相關優勢。

PICC 通常插入患有多種疾病（包括癌症和感染）的患者手臂靜脈中，用於給藥和液體營養。

PICC 允許長期輸液和抽血。這使得醫生能夠進入靠近心臟的大中央靜脈以進行有效的藥物管理。

PICC 疼痛較小，並且可以避免頻繁的針刺。它還可以降低刺激手臂小靜脈的風險。

PICC的另一個優點是它具有多個流明。由多個來源供給的管子和蓋子構成了管腔。因此，患者可以同時接受多種藥物治療。例如，您可以同時接受靜脈輸液和化療。

因此，考慮到與週邊插入中心靜脈導管（PICC）相關的優勢，該產品類別預計將最終產生可觀的收入份額，並為預測期內整體血管通路器械市場的成長做出貢獻。

北美預計將主導整個血管通路器械市場

預計在預測期內，北美將主導整個血管通路器械市場。這一優點是由於對血管通路裝置先進技術的需求增加、慢性病和傳染病患者的治療需求增加以及其他地區產品開發活動的增加所致。

根據American Cancer Society引用的統計數據，2023年美國將報告約82,290例膀胱癌新病例（約62,420名男性和19,870名女性）。

本報告提供了全球血管通路器械市場的研究和分析，包括市場規模和預測、驅動因素和挑戰以及公司和產品概況。

目錄

第1章 血管通路設備市場報告簡介

第2章 血管接取裝置市場執行摘要

  • 調查範圍
  • 市場概況
  • 競爭評估

第3章 監管分析

  • 美國
  • 歐洲
  • 日本
  • 中國

第4章 血管接入器械市場關鍵因素分析

  • 血管接入設備市場驅動因素
    • 慢性病流行
    • 增加化療
    • 兒科患者生活方式相關疾病的發生率增加
  • 血管通路器械市場的限制與挑戰
    • 這些設備放置不當
    • 這些設備的成本很高
  • 血管接取裝置的市場機會
    • 人們對腎臟病患者適當補水的興趣日益濃厚
    • 提高塗有生物活性材料的設備的可用性

第5章 血管通路裝置的波特五力分析

第6章 血管通路器械市場佈局

  • 按設備類型
    • 中心靜脈存取裝置
    • 週邊靜脈接入裝置
  • 按插入路徑
    • 靜脈
    • 皮下
  • 按最終用戶
    • 醫院
    • 門診手術中心
    • 其他
  • 按地區
    • 北美血管接取裝置市場（2021-2030）
    • 歐洲血管接取裝置市場（2021-2030）
    • 亞太地區血管接入器械市場（2021-2030）
    • 其他地區血管接入器械市場（2021-2030）

第7章 血管通路器械公司及產品簡介

  • Cook Medical Inc.
  • Becton, Dickinson, and Company
  • Teleflex Incorporated
  • Medtronic PLC
  • B Braun Melsungen AG
  • Nipro Medical Corporation
  • Smiths Group PLC
  • C. R. Bard, Inc.
  • Edwards Lifesciences Corporation
  • AngioDynamics
  • Terumo Medical Corporation
  • Amecath Medical Technologies
  • Prodimed
  • B Braun Melsungen AG
  • Zoll Medical Corporation

第8章 KOL觀點

第9章 專案方法

第10章 DelveInsight服務內容

第11章 關於 DelveInsight

第12章 免責聲明與聯絡我們

Product Code: DIMDCL0026

Vascular Access Device Market By Device Type (Central Vascular Access Device [Peripherally Inserted Central Catheters (PICC), Non-Tunneled Catheters, and Others], and Peripheral Vascular Access Device [Peripheral Catheter, Midline Catheter (Short) Devices, and Others]), Route Of Insertion (Intravenous and Subcutaneous), End-User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography is expected to grow at a steady CAGR forecast till 2030 owing to increasing prevalence of infectious diseases and rising technological advancements in the product portfolio

The global vascular access device market was valued at USD 4.59 billion in 2023, growing at a CAGR of 6.64% during the forecast period from 2024 to 2030, to reach USD 6.75 billion by 2030. The demand for vascular access device is primarily motivated by the growing prevalence of chronic diseases like cancer, kidney failure, and heart diseases that requires the use of these devices. Some other factors like the rise in the number of chemotherapies, lifestyle diseases, and their rising occurrence in pediatric patients may drive the growth of the market.

Vascular Access Device Market Dynamics:

The increasing prevalence of chronic and infectious diseases globally is going to accelerate the growth of the vascular access device market. For instance, according to Global Cancer Observatory data 2020, globally about 573 thousand cases of bladder cancer were reported in 2020. As per the same source, it has been estimated that by 2040, the number is likely to reach up to 913 thousand.

As per the above-mentioned source, worldwide around 431 thousand new cancer cases of kidney and renal pelvis were diagnosed in 2020 and the cases are expected to increase to 606 thousand by 2040.

The Globocan 2020 says that, worldwide 1.41 million new cases of prostate cancer were registered in 2020. As per the same source, around 2.24 million new cases of prostate cancer are going to be recorded in 2040.

The latest data published by the International Society of Nephrology stated that, worldwide, 850 million people were living with some form of kidney disease in 2022. The source further mentioned that between 5.3 and 10.5 million people needed dialysis or transplantation globally.

However, complications and high costs associated with different vascular access devices may restrict the growth of the overall vascular devices market.

Vascular Access Device Market Segment Analysis:

Vascular Access Device by Device Type (Central Vascular Access Device [Peripherally Inserted Central Catheter (PICC), Non-Tunneled Catheters, and Others], and Peripheral Vascular Access Device [Peripheral Catheter, Midline Catheter (short) Devices, and Others]), Route of Insertion (Intravenous and Subcutaneous), End-User (Hospitals, Ambulatory Surgical Centres, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the device type segment of the vascular access device market, the peripherally inserted central catheters (PICC) category under the central vascular access device is expected to hold the largest share. This is owing to the advantages that are associated with PICC.

PICCS are generally used to give medications or liquid nutrition upon insertion through a vein in the arm of patients suffering from various diseases including cancer, infectious diseases, and others.

PICCs allow for long-term access to inject fluids or draw blood. These allow doctors to access the large central veins near the heart for effective administration of medications.

PICCs are associated with less pain and help avoid frequent needle sticks. They also reduce the risk of irritation to the smaller veins present in the arms.

The fact that PICCs can have several lumens is another advantage. The tubing and caps that feed from multiple sources make up a lumen. As a result, a patient may receive multiple medications at once. For instance, they might have fluids and chemotherapy at the same time.

Therefore, considering the advantages associated with peripherally inserted central catheters (PICCs), this product category is expected to generate significant revenue share eventually contributing to the overall growth of the vascular access device market in the forecast period.

North America is expected to dominate the overall Vascular Access Device Market:

North America is expected to dominate the overall vascular access device market during the forecast period. This domination is due to the growing demand for advanced technologies in vascular access devices, the rising need to treat patients suffering from chronic and infectious diseases, and increasing product development activities in the region among others.

The statistics cited by the American Cancer Society, in 2023, stated that about 82,290 new cases of bladder cancer (about 62,420 in men and 19,870 in women will be reported in the US.

According to the Centre for Disease Control and Prevention (CDC) 2020, Cystic fibrosis (CF), a genetic disorder that causes problems with breathing and digestion affects about 35,000 people in the United States, every year on average.

In addition, people suffering from cystic fibrosis need intravenous (IV) antibiotic treatments for more than just a few days, such as during an exacerbation, which could potentially raise the demand for vascular access devices such as PICCs and others.

Also, a rise in hospital enrolment due to a surge in infectious diseases that require the administration of medications in the veins will contribute to the vascular access devices market growth.

For instance, according to CDC 2022, it was estimated that around 1,189,700 people aged 13 and above had HIV in the US in 2019.

Moreover, continuous regulatory approvals in the region are likely to boost the demand for vascular access devices in the coming years. For example, in March 2020, the Biowy PICC-S kit received 510(k) clearance from the US FDA.

Therefore, along with the presence of a large patient pool in the country, the increasing focus of key manufacturers on launching new products in the market is expected to bolster the growth of the vascular access device market in the United States during the forecast period.

Vascular Access Device Market Key Players:

Some of the key market players operating in the vascular access device market include Cook Medical Inc., Becton, Dickinson, and Company, Teleflex Incorporated, Medtronic PLC, Zoll Medical Corporation, B Braun Melsungen AG, Prodimed, Amecath Medical Technologies, Terumo Medical Corporation, AngioDynamics, Edwards Lifesciences Corporation, C. R. Bard, Inc., Smiths Group PLC, Nipro Medical Corporation, and others.

Recent Developmental Activities in the Vascular Access Device Market:

In August 2021, PuraCath Medical(TM), a venture-backed startup company focusing on the development of technologies to reduce infections in patients with intravascular catheters, announced that it has received 510(k) clearance for its FireFly(TM) Needleless Connector from the US Food and Drug Administration (FDA). The Firefly(TM) Needleless Connector is a sterile single-patient-use connector for needleless access to the IV line and IV catheter during IV therapy and can be used for direct injection, intermittent infusion, continuous infusion, or aspiration. This regulatory determination by the FDA gives PuraCath clearance to market the FireFly(TM) needleless connector in the US.

In July 2021, Artio Medical, Inc., a medical device company developing innovative products for the peripheral vascular, neurovascular, and structural heart markets, announced it has completed enrolment in its first-in-human study evaluating the company's Amplifi(TM) Vein Dilation System. The Amplifi System is designed to stimulate arm vein enlargement in hemodialysis patients using rapid, non-pulsatile venous blood flow. A novel vein dilation system aims to improve vascular access for hemodialysis patients.

Key Takeaways from the Vascular Access Device Market Report Study

Market size analysis for current market size (2023), and market forecast for 5 years (2024-2030)

Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years

Key companies are dominating the global vascular access device market.

Various opportunities are available for the other competitor in the vascular access devices market space.

What are the top-performing segments in 2023? How these segments will perform in 2030?

Which are the top-performing regions and countries in the current market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for vascular access devices market growth in the coming future?

Target audience who can be benefited from this Vascular Access Device Market Key Report Study

Vascular access devices providers

Research organizations and consulting companies

Vascular Access Devices related organizations, associations, forums, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders in vascular access devices

Various end-users want to know more about the vascular access devices market and the latest technological developments in the vascular access devices market

Frequently Asked Questions for Vascular Access Device Market:

What are Vascular Access Device?

Vascular access device are types of equipment that are inserted inside the body through a vein to enable the administration of fluids, blood products, medication, and other therapies to the bloodstream. These devices allow repeated and long-term access to the bloodstream for frequent or regular administration of drugs, like intravenous (IV) antibiotics. The vascular access tubes are made of silicone, latex, and other substances.

What is the market for global vascular access device?

The global vascular access devices market was valued at USD 4.59 billion in 2023, growing at a CAGR of 6.64% during the forecast period from 2024 to 2030, to reach USD 6.75 billion by 2030.

What are the drivers for global vascular access device?

The major drivers driving the demand for vascular access devices are the growing prevalence of chronic diseases like cancer, kidney failure, and heart diseases that requires the use of these devices. Some other factors like a rise in the number of chemotherapies, lifestyle diseases, and their rising occurrence in pediatric patients, technological advancements in product portfolio coupled with the rising number of product launches and approvals are going to assist in the growth of the vascular access devices market.

What are the key players operating in global vascular access devices?

Some of the key market players operating in the vascular access devices market include Becton, Dickinson, and Company, Teleflex Incorporated, Medtronic PLC, Zoll Medical Corporation, B Braun Melsungen AG, Prodimed, Amecath Medical Technologies, Terumo Medical Corporation, AngioDynamics, Edwards Lifesciences Corporation, C. R. Bard, Inc., Smiths Group PLC, Nipro Medical Corporation, and others.

What regions have the highest share in the vascular access devices market?

North America is expected to dominate the overall vascular access devices market during the forecast period, 2024 to 2030. This domination is due to the increasing number of patients with chronic and infectious diseases in the region, the presence of key players, the surge in product development activities, proper reimbursement, and others.

Table of Contents

1. Vascular Access Devices Market Report Introduction

2. Vascular Access Devices Market Executive Summary

  • 2.1. Scope of the Study
  • 2.2. Market at Glance
  • 2.3. Competitive Assessment

3. Regulatory Analysis

  • 3.1. The United States
  • 3.2. Europe
  • 3.3. Japan
  • 3.4. China

4. Vascular Access Devices Market Key factors analysis

  • 4.1. Vascular Access Devices Market Drivers
    • 4.1.1. Growing prevalence of chronic diseases
    • 4.1.2. Rise in the number of chemotherapies
    • 4.1.3. Rising occurrence of lifestyle diseases in pediatric patients
  • 4.2. Vascular Access Devices Market Restraints and Challenges
    • 4.2.1. Incorrect placement of these devices
    • 4.2.2. High cost of these devices
  • 4.3. Vascular Access Devices Market Opportunities
    • 4.3.1. Growing preference for adequate delivery of fluids in kidney disease patients
    • 4.3.2. Growing availability of devices coated with bioactive materials

5. Vascular Access Devices Porter's Five Forces Analysis

  • 5.1. Bargaining Power of Suppliers
  • 5.2. Bargaining Power of Consumers
  • 5.3. Threat of New Entrants
  • 5.4. Threat of Substitutes
  • 5.5. Competitive Rivalry

6. Vascular Access Devices Market layout

  • 6.1. By Device Type
    • 6.1.1. Central Vascular Access Devices
      • 6.1.1.1. Peripherally Inserted Central Catheters (PICC)
      • 6.1.1.2. Non-Tunneled Catheters
      • 6.1.1.3. Others
    • 6.2.1. Peripheral Vascular Access Devices
      • 6.2.1.1. Peripheral Catheter
      • 6.2.1.2. Midline Catheter (Short) Devices
      • 6.2.1.3. Others
  • 6.2. By Route of Insertion
    • 6.2.1. Intravenous
    • 6.2.2. Subcutaneous
  • 6.3. By End-User
    • 6.3.1. Hospitals
    • 6.3.2. Ambulatory Surgical Centres
    • 6.3.3. Others
  • 6.4. By Geography
    • 6.4.1. North America Vascular Access Devices Market in USD million (2021-2030)
      • 6.4.1.1. United States Vascular Access Devices Market in USD million (2021-2030)
      • 6.4.1.2. Canada Vascular Access Devices Market in USD million (2021-2030)
      • 6.4.1.3. Mexico Vascular Access Devices Market in USD million (2021-2030)
    • 6.4.2. Europe Vascular Access Devices Market in USD million (2021-2030)
      • 6.4.2.1. France Vascular Access Devices Market in USD million (2021-2030)
      • 6.4.2.2. Germany Vascular Access Devices Market in USD million (2021-2030)
      • 6.4.2.3. United Kingdom Vascular Access Devices Market in USD million (2021-2030)
      • 6.4.2.4. Italy Vascular Access Devices Market in USD million (2021-2030)
      • 6.4.2.5. Spain Vascular Access Devices Market in USD million (2021-2030)
      • 6.4.2.6. Rest of Europe Vascular Access Devices Market in USD million (2021-2030)
    • 6.4.3. Asia-Pacific Vascular Access Devices Market in USD million (2021-2030)
      • 6.4.3.1. China Vascular Access Devices Market in USD million (2021-2030)
      • 6.4.3.2. Japan Vascular Access Devices Market in USD million (2021-2030)
      • 6.4.3.3. India Vascular Access Devices Market in USD million (2021-2030)
      • 6.4.3.4. Australia Vascular Access Devices Market in USD million (2021-2030)
      • 6.4.3.5. South Korea Vascular Access Devices Market in USD million (2021-2030)
      • 6.4.3.6. Rest of Asia-Pacific Vascular Access Devices Market in USD million (2021-2030)
    • 6.4.4. Rest of the World (RoW) Vascular Access Devices Market in USD million (2021-2030)
      • 6.4.4.1. Middle East Vascular Access Devices Market in USD million (2021-2030)
      • 6.4.4.2. Africa Vascular Access Devices Market in USD million (2021-2030)
      • 6.4.4.3. South America Vascular Access Devices Market in USD million (2021-2030)

7. Vascular Access Devices Company and Product Profiles

  • 7.1. Cook Medical Inc.
    • 7.1.1. Company Overview
    • 7.1.2. Company Snapshot
    • 7.1.3. Financial Overview
    • 7.1.4. Product Listing
    • 7.1.5. Entropy
  • 7.2. Becton, Dickinson, and Company
    • 7.2.1. Company Overview
    • 7.2.2. Company Snapshot
    • 7.2.3. Financial Overview
    • 7.2.4. Product Listing
    • 7.2.5. Entropy
  • 7.3. Teleflex Incorporated
    • 7.3.1. Company Overview
    • 7.3.2. Company Snapshot
    • 7.3.3. Financial Overview
    • 7.3.4. Product Listing
    • 7.3.5. Entropy
  • 7.4. Medtronic PLC
    • 7.4.1. Company Overview
    • 7.4.2. Company Snapshot
    • 7.4.3. Financial Overview
    • 7.4.4. Product Listing
    • 7.4.5. Entropy
  • 7.5. B Braun Melsungen AG
    • 7.5.1. Company Overview
    • 7.5.2. Company Snapshot
    • 7.5.3. Financial Overview
    • 7.5.4. Product Listing
    • 7.5.5. Entropy
  • 7.6. Nipro Medical Corporation
    • 7.6.1. Company Overview
    • 7.6.2. Company Snapshot
    • 7.6.3. Financial Overview
    • 7.6.4. Product Listing
    • 7.6.5. Entropy
  • 7.7. Smiths Group PLC
    • 7.7.1. Company Overview
    • 7.7.2. Company Snapshot
    • 7.7.3. Financial Overview
    • 7.7.4. Product Listing
    • 7.7.5. Entropy
  • 7.8. C. R. Bard, Inc.
    • 7.8.1. Company Overview
    • 7.8.2. Company Snapshot
    • 7.8.3. Financial Overview
    • 7.8.4. Product Listing
    • 7.8.5. Entropy
  • 7.9. Edwards Lifesciences Corporation
    • 7.9.1. Company Overview
    • 7.9.2. Company Snapshot
    • 7.9.3. Financial Overview
    • 7.9.4. Product Listing
    • 7.9.5. Entropy
  • 7.10. AngioDynamics
    • 7.10.1. Company Overview
    • 7.10.2. Company Snapshot
    • 7.10.3. Financial Overview
    • 7.10.4. Product Listing
    • 7.10.5. Entropy
  • 7.11. Terumo Medical Corporation
    • 7.11.1. Company Overview
    • 7.11.2. Company Snapshot
    • 7.11.3. Financial Overview
    • 7.11.4. Product Listing
    • 7.11.5. Entropy
  • 7.12. Amecath Medical Technologies
    • 7.12.1. Company Overview
    • 7.12.2. Company Snapshot
    • 7.12.3. Financial Overview
    • 7.12.4. Product Listing
    • 7.12.5. Entropy
  • 7.13. Prodimed
    • 7.13.1. Company Overview
    • 7.13.2. Company Snapshot
    • 7.13.3. Financial Overview
    • 7.13.4. Product Listing
    • 7.13.5. Entropy
  • 7.14. B Braun Melsungen AG
    • 7.14.1. Company Overview
    • 7.14.2. Company Snapshot
    • 7.14.3. Financial Overview
    • 7.14.4. Product Listing
    • 7.14.5. Entropy
  • 7.15. Zoll Medical Corporation
    • 7.15.1. Company Overview
    • 7.15.2. Company Snapshot
    • 7.15.3. Financial Overview
    • 7.15.4. Product Listing
    • 7.15.5. Entropy

8. KOL Views

9. Project Approach

10. DelveInsight Capabilities

11. About DelveInsight

12. Disclaimer & Contact Us

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: Vascular Access Devices Market in Global (2021-2030)
  • Table 3: Vascular Access Devices Market in Global by Device Type (2021-2030)
  • Table 4: Vascular Access Devices Market in Global by Route of Insertion (2021-2030)
  • Table 5: Vascular Access Devices Market in Global by End-User (2021-2030)
  • Table 6: Vascular Access Devices Market in Global by Geography (2021-2030)
  • Table 7: Vascular Access Devices Market in North America (2021-2030)
  • Table 8: Vascular Access Devices Market in the US (2021-2030)
  • Table 9: Vascular Access Devices Market in Canada (2021-2030)
  • Table 10: Vascular Access Devices Market in Mexico (2021-2030)
  • Table 11: Vascular Access Devices Market in Europe (2021-2030)
  • Table 12: Vascular Access Devices Market in France (2021-2030)
  • Table 13: Vascular Access Devices Market in Germany (2021-2030)
  • Table 14: Vascular Access Devices Market in the United Kingdom (2021-2030)
  • Table 15: Vascular Access Devices Market in Italy (2021-2030)
  • Table 16: Vascular Access Devices Market in Spain (2021-2030)
  • Table 17: Vascular Access Devices Market in Rest of Europe (2021-2030)
  • Table 18: Vascular Access Devices Market in Asia Pacific (2021-2030)
  • Table 19: Vascular Access Devices Market in China (2021-2030)
  • Table 20: Vascular Access Devices Market in Japan (2021-2030)
  • Table 21: Vascular Access Devices Market in India (2021-2030)
  • Table 22: Vascular Access Devices Market in Australia (2021-2030)
  • Table 23: Vascular Access Devices Market in South Korea (2021-2030)
  • Table 24: Vascular Access Devices Market in Rest of Asia Pacific (2021-2030)
  • Table 25: Vascular Access Devices Market in the Rest of the World (2021-2030)
  • Table 26: Vascular Access Devices Market in the Middle East (2021-2030)
  • Table 27: Vascular Access Devices Market in Africa (2021-2030)
  • Table 28: Vascular Access Devices Market in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: Vascular Access Devices Market in Global (2021-2030)
  • Figure 3: Vascular Access Devices Market in Global by Device Type (2021-2030)
  • Figure 4: Vascular Access Devices Market in Global by Route of Insertion (2021-2030)
  • Figure 5: Vascular Access Devices Market in Global by End-User (2021-2030)
  • Figure 6: Vascular Access Devices Market in Global by Geography (2021-2030)
  • Figure 7: Vascular Access Devices Market in North America (2021-2030)
  • Figure 8: Vascular Access Devices Market in the US (2021-2030)
  • Figure 9: Vascular Access Devices Market in Canada (2021-2030)
  • Figure 10: Vascular Access Devices Market in Mexico (2021-2030)
  • Figure 11: Vascular Access Devices Market in Europe (2021-2030)
  • Figure 12: Vascular Access Devices Market in France (2021-2030)
  • Figure 13: Vascular Access Devices Market in Germany (2021-2030)
  • Figure 14: Vascular Access Devices Market in the United Kingdom (2021-2030)
  • Figure 15: Vascular Access Devices Market in Italy (2021-2030)
  • Figure 16: Vascular Access Devices Market in Spain (2021-2030)
  • Figure 17: Vascular Access Devices Market in the Rest of Europe (2021-2030)
  • Figure 18: Vascular Access Devices Market in Asia Pacific (2021-2030)
  • Figure 19: Vascular Access Devices Market in China (2021-2030)
  • Figure 20: Vascular Access Devices Market in Japan (2021-2030)
  • Figure 21: Vascular Access Devices Market in India (2021-2030)
  • Figure 22: Vascular Access Devices Market in Australia (2021-2030)
  • Figure 23: Vascular Access Devices Market in South Korea (2021-2030)
  • Figure 24: Vascular Access Devices Market in the Rest of Asia Pacific (2021-2030)
  • Figure 25: Vascular Access Devices Market in the Rest of the World (2021-2030)
  • Figure 26: Vascular Access Devices Market in the Middle East (2021-2030)
  • Figure 27: Vascular Access Devices Market in Africa (2021-2030)
  • Figure 28: Vascular Access Devices in South America (2021-2030)
  • Figure 29: Market Drivers
  • Figure 30: Market Barriers
  • Figure 31: Market Opportunities
  • Figure 32: PORTER'S Five Force Analysis